Ariel Pablos-Méndez
Director/Miembro de la Junta en Global Alliance for TB Drug Development .
Cargos activos de Ariel Pablos-Méndez
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Global Alliance for TB Drug Development
 Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Director/Miembro de la Junta | - | - |
ILiAD Biotechnologies LLC
 ILiAD Biotechnologies LLC BiotechnologyHealth Technology ILiAD Biotechnologies LLC operates as a clinical stage biotechnology company, focuses on the prevention and treatment of disease caused by Bordetella Pertussis. It offers BPZE1, a live-attenuated pertussis vaccine that has completed Phase 1 human clinical trial. The company was founded by Keith Rubin in 2012 and is headquartered in New York, NY. | Director/Miembro de la Junta | - | - |
Historial de carrera de Ariel Pablos-Méndez
Estadísticas
Internacional
| Estados Unidos | 3 |
Operativa
| Director/Board Member | 2 |
Sectorial
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Global Alliance for TB Drug Development
Global Alliance for TB Drug Development Pharmaceuticals: GenericHealth Technology Global Alliance for TB Drug Development operates as a not-for-profit organization dedicated to the discovery and development of tuberculosis drugs. It builds partnerships between the public, private, academic, and philanthropic sectors to drive the development of new products for underserved markets. The company was founded in February 2000 and is headquartered in New York , NY. | Health Technology |
ILiAD Biotechnologies LLC
ILiAD Biotechnologies LLC BiotechnologyHealth Technology ILiAD Biotechnologies LLC operates as a clinical stage biotechnology company, focuses on the prevention and treatment of disease caused by Bordetella Pertussis. It offers BPZE1, a live-attenuated pertussis vaccine that has completed Phase 1 human clinical trial. The company was founded by Keith Rubin in 2012 and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Ariel Pablos-Méndez
- Experiencia
